{"id":118749,"date":"2025-01-17T00:00:00","date_gmt":"2025-01-17T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2025\/01\/17\/tea-consumption-can-lower-mortality-in-chronic-kidney-disease\/"},"modified":"2025-01-22T16:10:23","modified_gmt":"2025-01-22T16:10:23","slug":"tea-consumption-can-lower-mortality-in-chronic-kidney-disease","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2025\/01\/17\/tea-consumption-can-lower-mortality-in-chronic-kidney-disease\/","title":{"rendered":"Tea Consumption Can Lower Mortality in Chronic Kidney Disease"},"content":{"rendered":"<h3>\n<p>Consuming up to four cups per day associated with lower all-cause mortality among patients with CKD stage 1 to 2<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><br \/>\n<b><\/b><\/p>\n<p>FRIDAY, Jan. 17, 2025 (HealthDay News) &#8212; Tea consumption offers protective effects on mortality among patients with chronic kidney disease (CKD), according to a study published online Jan. 13 in <em>Renal Failure<\/em>.<\/p>\n<p>Jin Li, Ph.D., from the Guangzhou University of Chinese Medicine in China, and colleagues examined the long-term impact of tea consumption among 17,575 patients with CKD from the National Health and Nutrition Examination Survey for 1999 to 2018.<\/p>\n<p>The researchers found there were 5,835 deaths during follow-up, including 1,823 cardiovascular-related deaths. Compared with never drinking tea, consuming up to four cups of tea per day was significantly associated with lower all-cause mortality among patients with CKD stage 1 to 2 (hazard ratio, 0.89; 95 percent confidence interval, 0.80 to 0.99; P = 0.04), after adjustment for confounding variables; the association between tea consumption and cardiovascular disease (CVD) mortality was not significant (hazard ratio, 0.87; 95 percent confidence interval, 0.72 to 1.05; P = 0.15). There was a dose-response effect observed, with the risks for all-cause mortality mitigated by consuming up to three to five cups of tea per day, especially in early CKD stages. In CKD stage 1 to 2, an intake of one cup per day higher of oxidized tea was associated with a 10 percent lower risk for all-cause mortality (hazard ratio, 0.90; 95 percent confidence interval, 0.82 to 0.99; P = 0.03). Replacing one cup of green tea with one cup of oxidized tea was associated with a significantly lower risk for all-cause and CVD mortality (hazard ratios [95 percent confidence intervals], 0.92 [0.86 to 0.98; P = 0.01] and 0.89 [0.80 to 1.00; P &lt; 0.05], respectively) in those with CKD stage 1 to 2.<\/p>\n<p>&#8220;We suggested that CKD patients limit their daily intake of tea to no more than four cups, and choose appropriate varieties and flavors, such as oxidized tea and sugar-free tea,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/www.tandfonline.com\/doi\/10.1080\/0886022X.2025.2449578\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><br \/>\n<i>Copyright &#169; 2025 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Consuming up to four cups per day associated with lower all-cause mortality among patients with CKD stage 1 to 2<\/p>\n","protected":false},"author":6,"featured_media":118894,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-118749","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/118749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=118749"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/118749\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/118894"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=118749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=118749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=118749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}